Welcome to EQUITY DEVELOPMENT

The UK's longest established regulated provider of sponsored equity research.

We launched EQUITY DEVELOPMENT in 1997 becoming the first ever  regulated provider of Sponsored Equity Research in the UK.

Our research teams are made up of expert analysts with deep understanding & experience in their sectors.  Our research is distributed to all relevant investment classes & commentators. (at no cost to the reader).

We have made our name by specialising in those companies who are not receiving the attention that they merit, using detailed commentary, appropriate valuation metrics and regular publications to help eradicate undervaluation in the medium term.

 

FREE REGISTRATION

Sign up today and access the very latest company research

LOG IN

For access to all company research please

Calcitech

CalciTech is commercialising its proprietary process for fabricating exceptionally pure synthetic calcium carbonate (SCC) from low cost raw materials. There are significant opportunities for SCC in billion-dollar global industries, including paper, food and pharmaceuticals.

Synthetic calcium carbonate used in billion dollar, global industries

Formal permitting received for German plant

Global roll-out underway

Project finance this year targeted

Delivery of targets would justify share price over 60p in the short term, 275p longer term

Publication Date:
March 27 2008

Calcitech; Green light for German plant

  • Qualification for financing grant
  • Principle terms agreed with HSH Nordbank
  • Execution of strategy to realise value

Publication Date:
November 30 2006

Calcitech; Strong performance

  • Positive feedback from trade events
  • Chinese patent granted

Publication Date:
January 19 2006

CalciTech; Exciting international newcomer to Ofex

  • Developed proprietary process for SCC, a fourth generation, coating pigment
  • Top quality material for high end solutions
  • Strong management team
  • Significant growth potential

Publication Date:
June 23 2005